Cargando…

Does Mass Azithromycin Distribution Impact Child Growth and Nutrition in Niger? A Cluster-Randomized Trial

BACKGROUND: Antibiotic use on animals demonstrates improved growth regardless of whether or not there is clinical evidence of infectious disease. Antibiotics used for trachoma control may play an unintended benefit of improving child growth. METHODOLOGY: In this sub-study of a larger randomized cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amza, Abdou, Yu, Sun N., Kadri, Boubacar, Nassirou, Baido, Stoller, Nicole E., Zhou, Zhaoxia, West, Sheila K., Bailey, Robin L., Gaynor, Bruce D., Keenan, Jeremy D., Porco, Travis C., Lietman, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161345/ https://www.ncbi.nlm.nih.gov/pubmed/25210836 http://dx.doi.org/10.1371/journal.pntd.0003128

Ejemplares similares

A Cluster-Randomized Controlled Trial Evaluating the Effects of Mass Azithromycin Treatment on Growth and Nutrition in Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial
por: O'Brien, Kieran S., et al.
Publicado: (2017)

Community Risk Factors for Ocular Chlamydia Infection in Niger: Pre-Treatment Results from a Cluster-Randomized Trachoma Trial
por: Amza, Abdou, et al.
Publicado: (2012)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger
por: Kim, Jessica S., et al.
Publicado: (2019)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Erratum to: Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2016)

Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2015)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Reliability of Trachoma Clinical Grading—Assessing Grading of Marginal Cases
por: Rahman, Salman A., et al.
Publicado: (2014)

Optimal Seasonal Timing of Oral Azithromycin for Malaria
por: Gao, Daozhou, et al.
Publicado: (2014)

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021)

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial
por: Arzika, Ahmed M., et al.
Publicado: (2021)

Elimination and Eradication of Neglected Tropical Diseases with Mass Drug Administrations: A Survey of Experts
por: Keenan, Jeremy D., et al.
Publicado: (2013)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)

Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger
por: Hazel, Ashley, et al.
Publicado: (2023)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)

Application of smartphone cameras for detecting clinically active trachoma
por: Bhosai, Satasuk Joy, et al.
Publicado: (2012)

Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger
por: Platts-Mills, James A, et al.
Publicado: (2022)

Risk Factors for Ocular Chlamydia after Three Mass Azithromycin Distributions
por: Ayele, Berhan, et al.
Publicado: (2011)

Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
por: Keenan, Jeremy D, et al.
Publicado: (2020)

Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial
por: Porco, Travis C, et al.
Publicado: (2019)

Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial
por: Oron, Assaf P., et al.
Publicado: (2020)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions
por: Porco, Travis C., et al.
Publicado: (2020)

Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trial
por: Arzika, Ahmed M., et al.
Publicado: (2023)

Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment
por: Kim, Matthew C., et al.
Publicado: (2019)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
por: Liu, Fengchen, et al.
Publicado: (2014)

Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
por: Lietman, Thomas M., et al.
Publicado: (2015)

Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2020)

Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial
por: Arzika, Ahmed M, et al.
Publicado: (2021)

A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol
por: Sié, Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_15oj596104shn9sd23ji4kqh7r